InvestorsObserver
×
News Home

Is Illumina, Inc. (ILMN) a Poor Choice in the Healthcare Sector?

Friday, December 08, 2023 03:20 PM | InvestorsObserver Analysts

Mentioned in this article

Is Illumina, Inc. (ILMN) a Poor Choice in the Healthcare Sector?

A rating of 10 puts Illumina, Inc. (ILMN) near the top of the Healthcare sector according to InvestorsObserver. Illumina, Inc.'s score of 10 means that it ranks higher than 10% of stocks in the sector. In addition, its overall score of 1 ranks it higher than 1% of all stocks.

Overall Score - 1
ILMN has an Overall Score of 1. Find out what this means to you and get the rest of the rankings on ILMN!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 1 means the stock is more attractive than 1 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Illumina, Inc. Stock Today?

Illumina, Inc. (ILMN) stock is lower by -2.75% while the S&P 500 has risen 0.42% as of 3:12 PM on Friday, Dec 8. ILMN is lower by -$3.22 from the previous closing price of $117.13 on volume of 1,019,981 shares. Over the past year the S&P 500 has risen 16.18% while ILMN is lower by -45.87%. ILMN lost -$7.12 per share the over the last 12 months. Click Here to get the full Stock Report for Illumina, Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App